Guo, C., Zhao, D., Zhang, Q., Liu, S., & Sun, M. (2018). miR-429 suppresses tumor migration and invasion by targeting CRKL in hepatocellular carcinoma via inhibiting Raf/MEK/ERK pathway and epithelial-mesenchymal transition. Nature Portfolio.
Cita Chicago Style (17a ed.)Guo, Chunmei, Dongting Zhao, Qiuling Zhang, Shuqing Liu, y Ming-Zhong Sun. MiR-429 Suppresses Tumor Migration and Invasion by Targeting CRKL in Hepatocellular Carcinoma via Inhibiting Raf/MEK/ERK Pathway and Epithelial-mesenchymal Transition. Nature Portfolio, 2018.
Cita MLA (8a ed.)Guo, Chunmei, et al. MiR-429 Suppresses Tumor Migration and Invasion by Targeting CRKL in Hepatocellular Carcinoma via Inhibiting Raf/MEK/ERK Pathway and Epithelial-mesenchymal Transition. Nature Portfolio, 2018.